Motor behavior abnormalities in drug‐naïve patients with schizophrenia spectrum disorders
Identifieur interne : 000352 ( Istex/Corpus ); précédent : 000351; suivant : 000353Motor behavior abnormalities in drug‐naïve patients with schizophrenia spectrum disorders
Auteurs : Victor Peralta ; Maria S. Campos ; Elena García De Jal N ; Manuel J. CuestaSource :
- Movement Disorders [ 0885-3185 ] ; 2010-06-15.
English descriptors
- KwdEn :
Abstract
Prevalence and correlates of primary motor abnormalities in schizophrenia are presently ill defined. This study was aimed at examining the prevalence, syndromic structure, external correlates, and response to antipsychotic medication of a broad array of primary motor abnormalities. Two‐hundred antipsychotic‐naive patients with schizophrenia spectrum disorders were examined for motor abnormalities using the Modified Rogers Scale. Thirty‐one motor signs were subjected to factor analysis, and the resulting factors examined for association with a number of risk factors, clinical and psychopathological variables. One‐hundred and eighty‐nine patients were reassessed for motor abnormalities after completing a 4‐week trial with antipsychotic medication. Prevalence rates for at least one motor sign and syndrome at baseline were 66% and 40%, respectively. Motor signs clustered together into seven clinically interpretable factors: abnormal involuntary movements, hypokinesia, retarded catatonia, echo‐phenomena, excited catatonia, catalepsy, and parkinsonism. All motor domains but parkinsonism were inter‐related. Abnormal involuntary movements were associated with variables indicating both neurodevelopmental dysfunction and illness severity, and most motor domains were closely related to negative or disorganization symptoms. Change scores in motor domains after treatment with antipsychotic medication indicated improvement for abnormal involuntary movements, hypokinesia, retarded catatonia, excited catatonia and echophenomena, and worsening for parkinsonism. It is concluded that primary motor dysfunction is a prevalent and heterogeneous condition of schizophrenia. Motor abnormalities segregate into various syndromes, which have different clinical correlates and a differential response pattern to antipsychotic medication. It is hypothesized that the existence of a differential dopaminergic dysfunction in the nigroestriatal circuitry is responsible for the generation of those motor domains that improve and worsen with antipsychotic drugs. © 2010 Movement Disorder Society
Url:
DOI: 10.1002/mds.23050
Links to Exploration step
ISTEX:97A26A80FADED766EFBC5964EB8F004FE0F3F083Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Motor behavior abnormalities in drug‐naïve patients with schizophrenia spectrum disorders</title>
<author><name sortKey="Peralta, Victor" sort="Peralta, Victor" uniqKey="Peralta V" first="Victor" last="Peralta">Victor Peralta</name>
<affiliation><mods:affiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Campos, Maria S" sort="Campos, Maria S" uniqKey="Campos M" first="Maria S." last="Campos">Maria S. Campos</name>
<affiliation><mods:affiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="De Jal N, Elena Garcia" sort="De Jal N, Elena Garcia" uniqKey="De Jal N E" first="Elena García" last="De Jal N">Elena García De Jal N</name>
<affiliation><mods:affiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Cuesta, Manuel J" sort="Cuesta, Manuel J" uniqKey="Cuesta M" first="Manuel J." last="Cuesta">Manuel J. Cuesta</name>
<affiliation><mods:affiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:97A26A80FADED766EFBC5964EB8F004FE0F3F083</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1002/mds.23050</idno>
<idno type="url">https://api.istex.fr/document/97A26A80FADED766EFBC5964EB8F004FE0F3F083/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000352</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Motor behavior abnormalities in drug‐naïve patients with schizophrenia spectrum disorders</title>
<author><name sortKey="Peralta, Victor" sort="Peralta, Victor" uniqKey="Peralta V" first="Victor" last="Peralta">Victor Peralta</name>
<affiliation><mods:affiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Campos, Maria S" sort="Campos, Maria S" uniqKey="Campos M" first="Maria S." last="Campos">Maria S. Campos</name>
<affiliation><mods:affiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="De Jal N, Elena Garcia" sort="De Jal N, Elena Garcia" uniqKey="De Jal N E" first="Elena García" last="De Jal N">Elena García De Jal N</name>
<affiliation><mods:affiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Cuesta, Manuel J" sort="Cuesta, Manuel J" uniqKey="Cuesta M" first="Manuel J." last="Cuesta">Manuel J. Cuesta</name>
<affiliation><mods:affiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-06-15">2010-06-15</date>
<biblScope unit="vol">25</biblScope>
<biblScope unit="issue">8</biblScope>
<biblScope unit="page" from="1068">1068</biblScope>
<biblScope unit="page" to="1076">1076</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">97A26A80FADED766EFBC5964EB8F004FE0F3F083</idno>
<idno type="DOI">10.1002/mds.23050</idno>
<idno type="ArticleID">MDS23050</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>antipsychotics</term>
<term>catatonic signs</term>
<term>extrapyramidal signs</term>
<term>factor structure</term>
<term>motor abnormalities</term>
<term>schizophrenia</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Prevalence and correlates of primary motor abnormalities in schizophrenia are presently ill defined. This study was aimed at examining the prevalence, syndromic structure, external correlates, and response to antipsychotic medication of a broad array of primary motor abnormalities. Two‐hundred antipsychotic‐naive patients with schizophrenia spectrum disorders were examined for motor abnormalities using the Modified Rogers Scale. Thirty‐one motor signs were subjected to factor analysis, and the resulting factors examined for association with a number of risk factors, clinical and psychopathological variables. One‐hundred and eighty‐nine patients were reassessed for motor abnormalities after completing a 4‐week trial with antipsychotic medication. Prevalence rates for at least one motor sign and syndrome at baseline were 66% and 40%, respectively. Motor signs clustered together into seven clinically interpretable factors: abnormal involuntary movements, hypokinesia, retarded catatonia, echo‐phenomena, excited catatonia, catalepsy, and parkinsonism. All motor domains but parkinsonism were inter‐related. Abnormal involuntary movements were associated with variables indicating both neurodevelopmental dysfunction and illness severity, and most motor domains were closely related to negative or disorganization symptoms. Change scores in motor domains after treatment with antipsychotic medication indicated improvement for abnormal involuntary movements, hypokinesia, retarded catatonia, excited catatonia and echophenomena, and worsening for parkinsonism. It is concluded that primary motor dysfunction is a prevalent and heterogeneous condition of schizophrenia. Motor abnormalities segregate into various syndromes, which have different clinical correlates and a differential response pattern to antipsychotic medication. It is hypothesized that the existence of a differential dopaminergic dysfunction in the nigroestriatal circuitry is responsible for the generation of those motor domains that improve and worsen with antipsychotic drugs. © 2010 Movement Disorder Society</div>
</front>
</TEI>
<istex><corpusName>wiley</corpusName>
<author><json:item><name>Victor Peralta MD, PhD</name>
<affiliations><json:string>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</json:string>
</affiliations>
</json:item>
<json:item><name>Maria S. Campos MD</name>
<affiliations><json:string>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</json:string>
</affiliations>
</json:item>
<json:item><name>Elena García De Jalón MD</name>
<affiliations><json:string>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</json:string>
</affiliations>
</json:item>
<json:item><name>Manuel J. Cuesta MD, PhD</name>
<affiliations><json:string>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</json:string>
</affiliations>
</json:item>
</author>
<subject><json:item><lang><json:string>eng</json:string>
</lang>
<value>motor abnormalities</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>catatonic signs</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>extrapyramidal signs</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>factor structure</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>schizophrenia</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>antipsychotics</value>
</json:item>
</subject>
<language><json:string>eng</json:string>
</language>
<abstract>Prevalence and correlates of primary motor abnormalities in schizophrenia are presently ill defined. This study was aimed at examining the prevalence, syndromic structure, external correlates, and response to antipsychotic medication of a broad array of primary motor abnormalities. Two‐hundred antipsychotic‐naive patients with schizophrenia spectrum disorders were examined for motor abnormalities using the Modified Rogers Scale. Thirty‐one motor signs were subjected to factor analysis, and the resulting factors examined for association with a number of risk factors, clinical and psychopathological variables. One‐hundred and eighty‐nine patients were reassessed for motor abnormalities after completing a 4‐week trial with antipsychotic medication. Prevalence rates for at least one motor sign and syndrome at baseline were 66% and 40%, respectively. Motor signs clustered together into seven clinically interpretable factors: abnormal involuntary movements, hypokinesia, retarded catatonia, echo‐phenomena, excited catatonia, catalepsy, and parkinsonism. All motor domains but parkinsonism were inter‐related. Abnormal involuntary movements were associated with variables indicating both neurodevelopmental dysfunction and illness severity, and most motor domains were closely related to negative or disorganization symptoms. Change scores in motor domains after treatment with antipsychotic medication indicated improvement for abnormal involuntary movements, hypokinesia, retarded catatonia, excited catatonia and echophenomena, and worsening for parkinsonism. It is concluded that primary motor dysfunction is a prevalent and heterogeneous condition of schizophrenia. Motor abnormalities segregate into various syndromes, which have different clinical correlates and a differential response pattern to antipsychotic medication. It is hypothesized that the existence of a differential dopaminergic dysfunction in the nigroestriatal circuitry is responsible for the generation of those motor domains that improve and worsen with antipsychotic drugs. © 2010 Movement Disorder Society</abstract>
<qualityIndicators><score>7.687</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>612 x 810 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractCharCount>2091</abstractCharCount>
<pdfWordCount>4687</pdfWordCount>
<pdfCharCount>36012</pdfCharCount>
<pdfPageCount>9</pdfPageCount>
<abstractWordCount>265</abstractWordCount>
</qualityIndicators>
<title>Motor behavior abnormalities in drug‐naïve patients with schizophrenia spectrum disorders</title>
<genre><json:string>Serial article</json:string>
</genre>
<host><volume>25</volume>
<pages><total>9</total>
<last>1076</last>
<first>1068</first>
</pages>
<issn><json:string>0885-3185</json:string>
</issn>
<issue>8</issue>
<subject><json:item><value>Research Article</value>
</json:item>
</subject>
<genre></genre>
<language><json:string>unknown</json:string>
</language>
<title>Movement Disorders</title>
<doi><json:string>10.1002/(ISSN)1531-8257</json:string>
</doi>
</host>
<publicationDate>2010</publicationDate>
<copyrightDate>2010</copyrightDate>
<doi><json:string>10.1002/mds.23050</json:string>
</doi>
<id>97A26A80FADED766EFBC5964EB8F004FE0F3F083</id>
<fulltext><json:item><original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/97A26A80FADED766EFBC5964EB8F004FE0F3F083/fulltext/pdf</uri>
</json:item>
<json:item><original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/97A26A80FADED766EFBC5964EB8F004FE0F3F083/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/97A26A80FADED766EFBC5964EB8F004FE0F3F083/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Motor behavior abnormalities in drug‐naïve patients with schizophrenia spectrum disorders</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability><p>Wiley Subscription Services, Inc., A Wiley Company</p>
</availability>
<date>2010</date>
</publicationStmt>
<notesStmt><note type="content">*Potential conflict of interest: Nothing to report.</note>
<note>Government of Navarra - No. 946/2005; No. 55/2007;</note>
</notesStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Motor behavior abnormalities in drug‐naïve patients with schizophrenia spectrum disorders</title>
<author><persName><forename type="first">Victor</forename>
<surname>Peralta</surname>
<roleName type="degree">MD, PhD</roleName>
</persName>
<note type="correspondence"><p>Correspondence: Psychiatric Unit, Virgen del Camino Hospital, Irunlarrea 4, Pamplona 31008, Spain</p>
</note>
<affiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</affiliation>
</author>
<author><persName><forename type="first">Maria S.</forename>
<surname>Campos</surname>
<roleName type="degree">MD</roleName>
</persName>
<affiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</affiliation>
</author>
<author><persName><forename type="first">Elena García</forename>
<surname>De Jalón</surname>
<roleName type="degree">MD</roleName>
</persName>
<affiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</affiliation>
</author>
<author><persName><forename type="first">Manuel J.</forename>
<surname>Cuesta</surname>
<roleName type="degree">MD, PhD</roleName>
</persName>
<affiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</affiliation>
</author>
</analytic>
<monogr><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="pISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<idno type="DOI">10.1002/(ISSN)1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-06-15"></date>
<biblScope unit="vol">25</biblScope>
<biblScope unit="issue">8</biblScope>
<biblScope unit="page" from="1068">1068</biblScope>
<biblScope unit="page" to="1076">1076</biblScope>
</imprint>
</monogr>
<idno type="istex">97A26A80FADED766EFBC5964EB8F004FE0F3F083</idno>
<idno type="DOI">10.1002/mds.23050</idno>
<idno type="ArticleID">MDS23050</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>2010</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
<abstract xml:lang="en"><p>Prevalence and correlates of primary motor abnormalities in schizophrenia are presently ill defined. This study was aimed at examining the prevalence, syndromic structure, external correlates, and response to antipsychotic medication of a broad array of primary motor abnormalities. Two‐hundred antipsychotic‐naive patients with schizophrenia spectrum disorders were examined for motor abnormalities using the Modified Rogers Scale. Thirty‐one motor signs were subjected to factor analysis, and the resulting factors examined for association with a number of risk factors, clinical and psychopathological variables. One‐hundred and eighty‐nine patients were reassessed for motor abnormalities after completing a 4‐week trial with antipsychotic medication. Prevalence rates for at least one motor sign and syndrome at baseline were 66% and 40%, respectively. Motor signs clustered together into seven clinically interpretable factors: abnormal involuntary movements, hypokinesia, retarded catatonia, echo‐phenomena, excited catatonia, catalepsy, and parkinsonism. All motor domains but parkinsonism were inter‐related. Abnormal involuntary movements were associated with variables indicating both neurodevelopmental dysfunction and illness severity, and most motor domains were closely related to negative or disorganization symptoms. Change scores in motor domains after treatment with antipsychotic medication indicated improvement for abnormal involuntary movements, hypokinesia, retarded catatonia, excited catatonia and echophenomena, and worsening for parkinsonism. It is concluded that primary motor dysfunction is a prevalent and heterogeneous condition of schizophrenia. Motor abnormalities segregate into various syndromes, which have different clinical correlates and a differential response pattern to antipsychotic medication. It is hypothesized that the existence of a differential dopaminergic dysfunction in the nigroestriatal circuitry is responsible for the generation of those motor domains that improve and worsen with antipsychotic drugs. © 2010 Movement Disorder Society</p>
</abstract>
<textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head>
<item><term>motor abnormalities</term>
</item>
<item><term>catatonic signs</term>
</item>
<item><term>extrapyramidal signs</term>
</item>
<item><term>factor structure</term>
</item>
<item><term>schizophrenia</term>
</item>
<item><term>antipsychotics</term>
</item>
</list>
</keywords>
</textClass>
<textClass><keywords scheme="Journal Subject"><list><head>Article category</head>
<item><term>Research Article</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc><change when="2009-11-13">Received</change>
<change when="2010-01-18">Registration</change>
<change when="2010-06-15">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/97A26A80FADED766EFBC5964EB8F004FE0F3F083/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8257</doi>
<issn type="print">0885-3185</issn>
<issn type="electronic">1531-8257</issn>
<idGroup><id type="product" value="MDS"></id>
</idGroup>
<titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title>
<title type="short">Mov. Disord.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="80"><doi origin="wiley" registered="yes">10.1002/mds.v25:8</doi>
<numberingGroup><numbering type="journalVolume" number="25">25</numbering>
<numbering type="journalIssue">8</numbering>
</numberingGroup>
<coverDate startDate="2010-06-15">15 June 2010</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="150" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.23050</doi>
<idGroup><id type="unit" value="MDS23050"></id>
</idGroup>
<countGroup><count type="pageTotal" number="9"></count>
</countGroup>
<titleGroup><title type="articleCategory">Research Article</title>
<title type="tocHeading1">Research Articles</title>
</titleGroup>
<copyright ownership="thirdParty">Copyright © 2010 Movement Disorder Society</copyright>
<eventGroup><event type="manuscriptReceived" date="2009-11-13"></event>
<event type="manuscriptRevised" date="2009-12-17"></event>
<event type="manuscriptAccepted" date="2010-01-18"></event>
<event type="firstOnline" date="2010-03-10"></event>
<event type="publishedOnlineFinalForm" date="2010-06-09"></event>
<event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2010-03-10"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.4.7 mode:FullText source:FullText result:FullText" date="2011-02-24"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event>
</eventGroup>
<numberingGroup><numbering type="pageFirst">1068</numbering>
<numbering type="pageLast">1076</numbering>
</numberingGroup>
<correspondenceTo>Psychiatric Unit, Virgen del Camino Hospital, Irunlarrea 4, Pamplona 31008, Spain</correspondenceTo>
<linkGroup><link type="toTypesetVersion" href="file:MDS.MDS23050.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta><countGroup><count type="figureTotal" number="0"></count>
<count type="tableTotal" number="5"></count>
<count type="referenceTotal" number="51"></count>
<count type="wordTotal" number="8501"></count>
</countGroup>
<titleGroup><title type="main" xml:lang="en">Motor behavior abnormalities in drug‐naïve patients with schizophrenia spectrum disorders<link href="#fn1"></link>
</title>
<title type="short" xml:lang="en">Motor Abnormalities in Schizophrenia</title>
</titleGroup>
<creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Victor</givenNames>
<familyName>Peralta</familyName>
<degrees>MD, PhD</degrees>
</personName>
<contactDetails><email>victor.peralta.martin@cfnavarra.es</email>
</contactDetails>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Maria S.</givenNames>
<familyName>Campos</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Elena García</givenNames>
<familyName>De Jalón</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Manuel J.</givenNames>
<familyName>Cuesta</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
</creators>
<affiliationGroup><affiliation xml:id="af1" countryCode="ES" type="organization"><unparsedAffiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">motor abnormalities</keyword>
<keyword xml:id="kwd2">catatonic signs</keyword>
<keyword xml:id="kwd3">extrapyramidal signs</keyword>
<keyword xml:id="kwd4">factor structure</keyword>
<keyword xml:id="kwd5">schizophrenia</keyword>
<keyword xml:id="kwd6">antipsychotics</keyword>
</keywordGroup>
<fundingInfo><fundingAgency>Government of Navarra</fundingAgency>
<fundingNumber>946/2005</fundingNumber>
<fundingNumber>55/2007</fundingNumber>
</fundingInfo>
<abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title>
<p>Prevalence and correlates of primary motor abnormalities in schizophrenia are presently ill defined. This study was aimed at examining the prevalence, syndromic structure, external correlates, and response to antipsychotic medication of a broad array of primary motor abnormalities. Two‐hundred antipsychotic‐naive patients with schizophrenia spectrum disorders were examined for motor abnormalities using the Modified Rogers Scale. Thirty‐one motor signs were subjected to factor analysis, and the resulting factors examined for association with a number of risk factors, clinical and psychopathological variables. One‐hundred and eighty‐nine patients were reassessed for motor abnormalities after completing a 4‐week trial with antipsychotic medication. Prevalence rates for at least one motor sign and syndrome at baseline were 66% and 40%, respectively. Motor signs clustered together into seven clinically interpretable factors: abnormal involuntary movements, hypokinesia, retarded catatonia, echo‐phenomena, excited catatonia, catalepsy, and parkinsonism. All motor domains but parkinsonism were inter‐related. Abnormal involuntary movements were associated with variables indicating both neurodevelopmental dysfunction and illness severity, and most motor domains were closely related to negative or disorganization symptoms. Change scores in motor domains after treatment with antipsychotic medication indicated improvement for abnormal involuntary movements, hypokinesia, retarded catatonia, excited catatonia and echophenomena, and worsening for parkinsonism. It is concluded that primary motor dysfunction is a prevalent and heterogeneous condition of schizophrenia. Motor abnormalities segregate into various syndromes, which have different clinical correlates and a differential response pattern to antipsychotic medication. It is hypothesized that the existence of a differential dopaminergic dysfunction in the nigroestriatal circuitry is responsible for the generation of those motor domains that improve and worsen with antipsychotic drugs. © 2010 Movement Disorder Society</p>
</abstract>
</abstractGroup>
</contentMeta>
<noteGroup><note xml:id="fn1"><p>Potential conflict of interest: Nothing to report.</p>
</note>
</noteGroup>
</header>
</component>
</istex:document>
</istex:metadataXml>
<!--Version 0.6 générée le 3-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Motor behavior abnormalities in drug‐naïve patients with schizophrenia spectrum disorders</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en"><title>Motor Abnormalities in Schizophrenia</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en"><title>Motor behavior abnormalities in drug‐naïve patients with schizophrenia spectrum disorders</title>
</titleInfo>
<name type="personal"><namePart type="given">Victor</namePart>
<namePart type="family">Peralta</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</affiliation>
<description>Correspondence: Psychiatric Unit, Virgen del Camino Hospital, Irunlarrea 4, Pamplona 31008, Spain</description>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Maria S.</namePart>
<namePart type="family">Campos</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Elena García</namePart>
<namePart type="family">De Jalón</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Manuel J.</namePart>
<namePart type="family">Cuesta</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>Psychiatric Unit, Virgen del Camino Hospital, Pamplona, Spain</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="originalCategForm">article</genre>
<originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place><placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2010-06-15</dateIssued>
<dateCaptured encoding="w3cdtf">2009-11-13</dateCaptured>
<dateValid encoding="w3cdtf">2010-01-18</dateValid>
<copyrightDate encoding="w3cdtf">2010</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription><internetMediaType>text/html</internetMediaType>
<extent unit="tables">5</extent>
<extent unit="references">51</extent>
<extent unit="words">8501</extent>
</physicalDescription>
<abstract lang="en">Prevalence and correlates of primary motor abnormalities in schizophrenia are presently ill defined. This study was aimed at examining the prevalence, syndromic structure, external correlates, and response to antipsychotic medication of a broad array of primary motor abnormalities. Two‐hundred antipsychotic‐naive patients with schizophrenia spectrum disorders were examined for motor abnormalities using the Modified Rogers Scale. Thirty‐one motor signs were subjected to factor analysis, and the resulting factors examined for association with a number of risk factors, clinical and psychopathological variables. One‐hundred and eighty‐nine patients were reassessed for motor abnormalities after completing a 4‐week trial with antipsychotic medication. Prevalence rates for at least one motor sign and syndrome at baseline were 66% and 40%, respectively. Motor signs clustered together into seven clinically interpretable factors: abnormal involuntary movements, hypokinesia, retarded catatonia, echo‐phenomena, excited catatonia, catalepsy, and parkinsonism. All motor domains but parkinsonism were inter‐related. Abnormal involuntary movements were associated with variables indicating both neurodevelopmental dysfunction and illness severity, and most motor domains were closely related to negative or disorganization symptoms. Change scores in motor domains after treatment with antipsychotic medication indicated improvement for abnormal involuntary movements, hypokinesia, retarded catatonia, excited catatonia and echophenomena, and worsening for parkinsonism. It is concluded that primary motor dysfunction is a prevalent and heterogeneous condition of schizophrenia. Motor abnormalities segregate into various syndromes, which have different clinical correlates and a differential response pattern to antipsychotic medication. It is hypothesized that the existence of a differential dopaminergic dysfunction in the nigroestriatal circuitry is responsible for the generation of those motor domains that improve and worsen with antipsychotic drugs. © 2010 Movement Disorder Society</abstract>
<note type="content">*Potential conflict of interest: Nothing to report.</note>
<note type="funding">Government of Navarra - No. 946/2005; No. 55/2007; </note>
<subject lang="en"><genre>Keywords</genre>
<topic>motor abnormalities</topic>
<topic>catatonic signs</topic>
<topic>extrapyramidal signs</topic>
<topic>factor structure</topic>
<topic>schizophrenia</topic>
<topic>antipsychotics</topic>
</subject>
<relatedItem type="host"><titleInfo><title>Movement Disorders</title>
</titleInfo>
<titleInfo type="abbreviated"><title>Mov. Disord.</title>
</titleInfo>
<subject><genre>article category</genre>
<topic>Research Article</topic>
</subject>
<identifier type="ISSN">0885-3185</identifier>
<identifier type="eISSN">1531-8257</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8257</identifier>
<identifier type="PublisherID">MDS</identifier>
<part><date>2010</date>
<detail type="volume"><caption>vol.</caption>
<number>25</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>8</number>
</detail>
<extent unit="pages"><start>1068</start>
<end>1076</end>
<total>9</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">97A26A80FADED766EFBC5964EB8F004FE0F3F083</identifier>
<identifier type="DOI">10.1002/mds.23050</identifier>
<identifier type="ArticleID">MDS23050</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2010 Movement Disorder Society</accessCondition>
<recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
<recordContentSource>WILEY</recordContentSource>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000352 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000352 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:97A26A80FADED766EFBC5964EB8F004FE0F3F083 |texte= Motor behavior abnormalities in drug‐naïve patients with schizophrenia spectrum disorders }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |